Clinical Trial Update: A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

View source ↗

Summary

A clinical trial registry entry for cirrhosis patients achieving sustained virologic response with a sofosbuvir-based, interferon-free regimen for chronic hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• sofosbuvir-based regimen (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Status: TERMINATED | Results posted: 2023-10-04